ENTITY

Aadi Bioscience (AADI US)

11
Analysis
Health Care • United States
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers. Aadi Bioscience serves patients in the United States.
more
•11 Dec 2025 01:06•Broker

BRIDS Market Pulse: Chart of the Week – ICBP P/E Band – Core Profit

JCI rose 1.5% w-w, outperforming majority of EM peers (except for Korea’s Kospi index +4.4% w-w), bringing YTD performance to 21.9%.

Logo
147 Views
Share
•28 Nov 2025 03:38•Broker

Coal: Demand Outlook Remains Soft, Though Seasonal Price Strength Still in Play (NEUTRAL)

Weak demand is partly balanced by constrained Indonesia’s production; government’s plan to cap 2026 production should be viewed positively.

Logo
181 Views
Share
•12 Nov 2025 06:04•Broker

Macro Strategy: Growth Over Differentials

Indonesia’s economy maintained solid momentum in 3Q25, recording 5.04% y-y (1.43% q-q) growth, although slightly easing from 2Q25’s 5.12%.

Logo
159 Views
Share
•03 Nov 2025 20:02•Broker

BRIDS Market Pulse : Chart of the Week – JCI Market Capitalization

MSCI has outlined two scenarios under this proposed method, which may effectively result in lower weighting for Indonesian stocks in MSCI EM Index.

Logo
206 Views
Share
bearish•Macroeconomics
•08 Sep 2025 20:11•Broker

BRIDS Market Pulse: Chart of the week – Metal sector vs. gold price

Foreign investors have continued to de-risk on largecap banks, namely BBCA (-US$195mn w-w, YTD: US$1.4bn) and BMRI (- US$45mn w-w, YTD: US$814mn).

Logo
257 Views
Share
x